Relafen or Naproxen 750, viewed examined from a biochemical molecular pharmacy perspective, represents a compelling vital illustration of NSAID or non-copyrightal anti-inflammatory drug action. Its mechanism process involves primarily substantially inhibiting cyclooxygenase prostaglandin synthetase